Organic Treatment of the Elderly

  • Philip L. Kapnick


Although clinical gerontology is a relatively new area of specialization, psychologists who practice in this field are committed to treatment goals which are similar to other areas of clinical psychology. Therapeutic goals, in a very general and ideal sense, are: to minimize the patient’s suffering, to improve behavior, to lessen interpersonal friction, and to assist the patient in taking pleasurable interest in his or her environment. To achieve these goals a combination of methods may be necessary. One method which is often used is psychopharmacology, the treatment of the emotionally disturbed with psychotropic medications. Even though psychologists do not prescribe medications, it is important for them to know what the various medications are, how they are used, what precautions should be taken in giving medications, and how medications affect behavior.


Psychotropic Drug Ergot Alkaloid Final MAOI Lithium Toxicity Magnesium Pemoline 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Abrams, R. Recent clinical studies of ECT. Seminars in Psychiatry, 1972, 4, 3–12.PubMedGoogle Scholar
  2. Anderson, W. F. and Judge, T. G. Geriatric medicine. New York: Academic Press, 1974.Google Scholar
  3. Avery, D. Drug treatment. Sydney, Australia: Adia Press (in collaboration with Acton, Mass.: Sciences Group), 1976.Google Scholar
  4. Avery, D. and Winokur, G. Mortality in depressed patients treated with electroconvulsive therapy and antidepressants. Archives of General Psychiatry, 1976, 33, 1029–1037.PubMedCrossRefGoogle Scholar
  5. Ayd, F. J. Rationale psychopharmacotherapy and the right to Google Scholar
  6. treatment. Baltimore: Ayd Medical Communications, Ltd., 1975.Google Scholar
  7. Balter, M. and Levine, J. The nature and extent of psychotropic drug usage in the United States. Psychopharmacology Bulletin, 1969, 5, 3–13.PubMedGoogle Scholar
  8. Benson, R. A. and Brodie, D. C. Suicide by overdoses of medicines among the aged. Journal of the American Geriatrics Society, 1975, 23, 304–308.PubMedGoogle Scholar
  9. Berger, F. M. Present status of clinical psychopharmacology. Clinical Pharmacy and Therapeutics, 1976, 19, 725–731.Google Scholar
  10. Black, P. Drugs and the brain. Baltimore: John Hopkins Press, 1970.Google Scholar
  11. Briant, R. H. Drug treatment in the elderly: Problems and prescribing rules. Drugs, 1977, 13, 225–229.PubMedCrossRefGoogle Scholar
  12. Butler, R. N. Psychiatry and the elderly: An overview. American Journal bf Psychiatry, 1975, 132, 893–900.Google Scholar
  13. Davis, J. M. and Casper, R. Antipsychotic drugs: Clinical pharmacology and therapeutic use. Drugs, 1977, 14, 260–282.PubMedCrossRefGoogle Scholar
  14. de Groot, M. H. L. The clinical use of psychotherapeutic drugs in the elderly. Drugs, 1974, 8, 132–138.PubMedCrossRefGoogle Scholar
  15. DiMascio, A. and Shader, R. I. (Eds.). Clinical handbook of psychopharmacology. New York: Science House, 1970.Google Scholar
  16. Eisdorfer, C. Observations on the psychopharmacology of the aged. Journal of the American Geriatrics Society, 1975, 23, 53–57.PubMedGoogle Scholar
  17. Eisdorfer, C. and Fann, W. E. (Eds.). Psychopharmacology and aging. New York: Plenum, 1973.Google Scholar
  18. Fann, W. E. Pharmacotherapy in older depressed patients. Journal of Gerontology, 1976, 31, 304–310.PubMedGoogle Scholar
  19. Fann, W. E. and Maddox, G. L. Drug issues in geropsychiatry. Baltimore: Williams & Wilkins, 1974.Google Scholar
  20. Fann, W. E., Wheless, J. C., and Richman, B. W. Treating the aged with psychotropic drugs. Gerontologist, 1976, 16, 322–328.PubMedCrossRefGoogle Scholar
  21. Fink, M. EEG classification of psychoactive compounds in man: A review and theory of behavioral associates. In D. Efron (Ed.), Psychopharmacology, U.S. PHS Pub. No. 1836, 1968.Google Scholar
  22. Fleminger, J. J. Differential effect of unilateral and bilateralGoogle Scholar
  23. ECT. American Journal of Psychiatry, 1970, 127, 437–442.Google Scholar
  24. Friedberg, J. Shock treatment is not good for your brain. San Francisco: Glide Publications, 1976.Google Scholar
  25. Frolkis, V. V. Aging of the autonomic nervous system. In J. Birren and K. W. Schaie (Eds.), The handbook of the psychology of aging. New York: Van Nostrand Reinhold, 1977.Google Scholar
  26. Fuchs, V. Who shall live. New York: Basic Books, 1974.Google Scholar
  27. Gaitz, C. M. Aging and the brain. New York: Plenum Press, 1972.Google Scholar
  28. Goodman, L. S. and Gilman, A. The pharmacological basis of therapeutics. New York: MacMillan, 1975.Google Scholar
  29. Hayflick, L. The cell biology of human aging. The New England Journal of Medicine, 1976, 295, 1302–1308.PubMedCrossRefGoogle Scholar
  30. Hollister, L. E. Clinical use of psychotherapeutic drugs. Springfield, Ill.: Charles C Thomas, 1973.Google Scholar
  31. Hollister, L. E. Drugs for mental disorders of old age. Journal of the American Medical Association, 1975, 234, 195–198.PubMedCrossRefGoogle Scholar
  32. Hollister, L. E. Mental disorders in the elderly. Drug Therapy, 1977, 7, 128–135.Google Scholar
  33. Jarvik, L. F. Aging and depression: Some unanswered questions. Journal of Gerontology, 1976, 31, 324–326.PubMedGoogle Scholar
  34. Jarvik, M. The psychopharmacological revolution. Psychology Today, 1967, 1, 51–59.Google Scholar
  35. Kapnick, P. L. Age differences in opinions of health care services. The Gerontologist, 1972, 12, 294–297.PubMedCrossRefGoogle Scholar
  36. Kastrup, E. K. (Ed.). Facts and comparisons. St. Louis: Facts and Comparisons, Inc., 1977.Google Scholar
  37. Klerman, G. L. Neuroleptics: Too many or too few. In F. Y. Ayd, Jr. (Ed.), Rational psychopharmacology and the right to treatment. Baltimore: Ayd Medical Communications, Ltd., 1975.Google Scholar
  38. Krai, V. A. Somatic therapies in older depressed patients. Journal of Gerontology, 1976, 31, 311–313.Google Scholar
  39. Leavitt, F. Drugs and behavior. Philadelphia: W. B. Saunders, 1974.Google Scholar
  40. Lipton, M. A. Age differences in depression: Biochemical aspects. Journal of Gerontology, 1976, 31, 293–299.PubMedGoogle Scholar
  41. Pitt, B. Psychogeriatrics: An introduction to the psychiatry of old age. London: Churchill Livingstone, 1974.Google Scholar
  42. Renschaw, D. C. Depression in the 1970’s. Diseases of the Nervous System, 1973, 34, 241–245.Google Scholar
  43. Ritschel, W. A. Pharmacokinetic approach to drug dosing in the aged. Journal of the American Geriatrics Society, 1976, 24, 344–354.PubMedGoogle Scholar
  44. Solomon, P. and Patch, V. D. Handbook of psychiatry. Los Altos: Lange Medical Publications, 1974.Google Scholar
  45. Whitehead, J. M. Psychiatric disorders in old age. New York: Springer Publishing Company, Inc., 1974.Google Scholar
  46. Woodruff, R. A., Goodwin, D. W., and Guze, S. D. Psychiatric diagnosis. New York: Oxford, 1974.Google Scholar

Copyright information

© Plenum Press, New York 1978

Authors and Affiliations

  • Philip L. Kapnick
    • 1
  1. 1.St. Louis College of PharmacyUSA

Personalised recommendations